| Nome |
# |
|
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression, file 054f9a4b-2c95-4826-a837-cca4a57e700a
|
238
|
|
Gut Microbiota and Cancer: From Pathogenesis to Therapy, file dfe4d229-897e-bb0a-e053-d805fe0a78d9
|
169
|
|
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease, file dfe4d22b-a96f-bb0a-e053-d805fe0a78d9
|
105
|
|
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?, file dfe4d22e-d593-bb0a-e053-d805fe0a78d9
|
99
|
|
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine, file dfe4d226-f3f8-bb0a-e053-d805fe0a78d9
|
91
|
|
Pericytes in microvessels: From “mural” function to brain and retina regeneration, file dfe4d22b-6a0b-bb0a-e053-d805fe0a78d9
|
83
|
|
Cutaneous melanoma: From pathogenesis to therapy, file dfe4d22b-b981-bb0a-e053-d805fe0a78d9
|
78
|
|
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment, file 09f25784-fc27-420f-b6a8-5d4dbef5f537
|
55
|
|
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma, file dfe4d22d-d734-bb0a-e053-d805fe0a78d9
|
49
|
|
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells, file dfe4d22b-a973-bb0a-e053-d805fe0a78d9
|
48
|
|
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation, file dfe4d229-97d0-bb0a-e053-d805fe0a78d9
|
42
|
|
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer, file dfe4d22d-7854-bb0a-e053-d805fe0a78d9
|
38
|
|
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy, file dfe4d227-2dfb-bb0a-e053-d805fe0a78d9
|
30
|
|
BRAF mutations in papillary thyroid carcinoma and emerging
targeted therapies (review), file dfe4d227-288d-bb0a-e053-d805fe0a78d9
|
25
|
|
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance, file dfe4d227-04fc-bb0a-e053-d805fe0a78d9
|
20
|
|
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer, file dfe4d22b-9cd0-bb0a-e053-d805fe0a78d9
|
20
|
|
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA, file dfe4d22b-c029-bb0a-e053-d805fe0a78d9
|
18
|
|
microRNAs and thyroid cancer: Biological and clinical significance (Review)., file dfe4d227-0c35-bb0a-e053-d805fe0a78d9
|
16
|
|
The tumor microenvironment in hepatocellular carcinoma, file dfe4d227-288a-bb0a-e053-d805fe0a78d9
|
15
|
|
Prognostic significance of deregulated microRNAs in uveal melanomas, file dfe4d22b-7aec-bb0a-e053-d805fe0a78d9
|
15
|
|
Environment and bladder cancer: Molecular analysis by interaction networks, file dfe4d22b-8722-bb0a-e053-d805fe0a78d9
|
15
|
|
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment, file dfe4d22e-33e7-bb0a-e053-d805fe0a78d9
|
14
|
|
Prediction of PD‐l1 expression in neuroblastoma via computational modeling, file dfe4d22b-88bb-bb0a-e053-d805fe0a78d9
|
13
|
|
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study, file dfe4d227-3cd9-bb0a-e053-d805fe0a78d9
|
12
|
|
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer, file dfe4d227-7fdf-bb0a-e053-d805fe0a78d9
|
12
|
|
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53, file d9442a84-8694-4eb6-b399-a2dcae1f5885
|
11
|
|
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance, file dfe4d227-1a9d-bb0a-e053-d805fe0a78d9
|
11
|
|
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance., file dfe4d227-38b3-bb0a-e053-d805fe0a78d9
|
11
|
|
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response, file dfe4d227-3df4-bb0a-e053-d805fe0a78d9
|
11
|
|
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity., file dfe4d227-4a8a-bb0a-e053-d805fe0a78d9
|
11
|
|
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker, file dfe4d227-7105-bb0a-e053-d805fe0a78d9
|
11
|
|
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells, file dfe4d22b-8724-bb0a-e053-d805fe0a78d9
|
11
|
|
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients, file a684820b-b49a-422e-92b3-eeea98cf8d5c
|
10
|
|
Cutaneous melanoma and the immunotherapy revolution (Review), file dfe4d22d-d738-bb0a-e053-d805fe0a78d9
|
10
|
|
Fluoro-edenite induces fibulin-3 overexpression
in non-malignant human mesothelial cells, file dfe4d227-30fe-bb0a-e053-d805fe0a78d9
|
9
|
|
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma, file dfe4d227-92b7-bb0a-e053-d805fe0a78d9
|
9
|
|
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs, file dfe4d22b-8721-bb0a-e053-d805fe0a78d9
|
9
|
|
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells, file dfe4d22b-b05c-bb0a-e053-d805fe0a78d9
|
9
|
|
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways, file dfe4d22e-d96e-bb0a-e053-d805fe0a78d9
|
9
|
|
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis, file dfe4d227-1a9c-bb0a-e053-d805fe0a78d9
|
8
|
|
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression, file dfe4d228-ab9f-bb0a-e053-d805fe0a78d9
|
8
|
|
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets, file dfe4d22d-7850-bb0a-e053-d805fe0a78d9
|
8
|
|
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review), file dfe4d22e-bb98-bb0a-e053-d805fe0a78d9
|
8
|
|
Emerging targeted therapies for melanoma treatment (review), file 135fc2cc-d6b2-4f25-b389-31df61a67b0e
|
7
|
|
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer, file dfe4d226-ffbc-bb0a-e053-d805fe0a78d9
|
7
|
|
Gsk-3β can regulate the sensitivity of mia-paca-2 pancreatic and mcf-7 breast cancer cells to chemotherapeutic drugs, targeted therapeutics and nutraceuticals, file 680e5c82-501a-4ac7-9473-3f353b42b117
|
6
|
|
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review), file 97111471-e059-479b-bda4-6180206579b0
|
6
|
|
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey, file dfe4d226-f7a4-bb0a-e053-d805fe0a78d9
|
6
|
|
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship, file dfe4d22e-b12b-bb0a-e053-d805fe0a78d9
|
6
|
|
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity, file 4e88949c-10d2-45cf-b502-095959497fc3
|
5
|
|
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer, file 509b8afe-b6ca-451e-a1c1-4e9a78a1623e
|
5
|
|
Cancer therapy and treatments during COVID-19 era, file af53ec31-565b-4137-a3b9-079f9007a456
|
5
|
|
YY1 silencing induces 5-fluorouracil-resistance and BCL2L15 downregulation in colorectal cancer cells: Diagnostic and prognostic relevance, file 45c2f483-b397-4e6f-a6ad-29f0818d8a9d
|
4
|
|
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer, file 3a4b2fb5-a30a-41f7-a79c-fff04f71664d
|
3
|
|
Editorial: Inflammation and aging in chronic and degenerative diseases: Current and future therapeutic strategies, file 3d7fd1fa-7253-4f8e-beec-09bcaf4bd096
|
3
|
|
Analysis of
the B-RafV600E mutation in cutaneous melanoma patients with occupational sun
exposure, file dfe4d227-9bfb-bb0a-e053-d805fe0a78d9
|
2
|
|
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development, file dfe4d229-b3e7-bb0a-e053-d805fe0a78d9
|
2
|
|
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals, file dfe4d22b-63e3-bb0a-e053-d805fe0a78d9
|
2
|
|
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines, file ea5b0f5f-59f8-4c41-85ef-e0a8eeaa0299
|
2
|
|
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53, file 5d88735e-7928-4bc7-81e8-fd6bccd97cd5
|
1
|
|
Nitric Oxide in Hematological Cancers: Partner or Rival?, file a0d6a3f6-58d5-4d6b-a6cb-e2537b1b810b
|
1
|
|
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells, file dfe4d227-0000-bb0a-e053-d805fe0a78d9
|
1
|
|
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis, file dfe4d227-042f-bb0a-e053-d805fe0a78d9
|
1
|
|
Molecular Targeted Therapy In Melanoma: A Way To Reverse Resistance To Conventional Drugs., file dfe4d227-1175-bb0a-e053-d805fe0a78d9
|
1
|
|
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder, file dfe4d227-3c58-bb0a-e053-d805fe0a78d9
|
1
|
|
Computational identification of microRNAs
associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer, file dfe4d227-7a67-bb0a-e053-d805fe0a78d9
|
1
|
|
Advances in targeting signal transduction pathways., file dfe4d227-7e18-bb0a-e053-d805fe0a78d9
|
1
|
|
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients., file dfe4d227-8e54-bb0a-e053-d805fe0a78d9
|
1
|
|
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy, file dfe4d227-915b-bb0a-e053-d805fe0a78d9
|
1
|
|
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention, file dfe4d227-9564-bb0a-e053-d805fe0a78d9
|
1
|
|
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells, file dfe4d227-b72d-bb0a-e053-d805fe0a78d9
|
1
|
|
Computational modelling in melanoma for novel drug discovery, file dfe4d22a-7a42-bb0a-e053-d805fe0a78d9
|
1
|
|
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells, file dfe4d22b-63e4-bb0a-e053-d805fe0a78d9
|
1
|
|
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals, file dfe4d22b-9cd2-bb0a-e053-d805fe0a78d9
|
1
|
|
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases., file dfe4d22b-b5e7-bb0a-e053-d805fe0a78d9
|
1
|
|
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines, file dfe4d22b-b5e9-bb0a-e053-d805fe0a78d9
|
1
|
| Totale |
1.582 |